The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis

Studies to confirm the effect of acknowledged prognostic markers in older breast cancer patients are scarce. The aim of this study was to evaluate the prognostic value of HER-2 overexpression and PIK3CA mutations in older breast cancer patients. Female breast cancer patients aged 65 years or older,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Engels, Charla C., Kiderlen, Mandy, Bastiaannet, Esther, van Eijk, Ronald, Mooyaart, Antien, Smit, Vincent T. H. B. M., de Craen, Anton J. M., Kuppen, Peter J. K., Kroep, Judith R., van de Velde, Cornelis J. H., Liefers, Gerrit Jan
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819549/
https://ncbi.nlm.nih.gov/pubmed/26968397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3734-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados